Ask VialBase
Narrative review · PMID 41490200

Therapeutic peptides in orthopaedic injuries — narrative review of BPC-157, TB-500, CJC-1295 + Ipamorelin, Tesamorelin, GHK-Cu — VialBase Research

CJC-1295 + ipamorelin activate IGF-1 signaling and satellite cell repair

Last updated · 2026 · Various · Orthopaedic Review
Key findings
  • CJC-1295 + ipamorelin activate IGF-1 signaling and satellite cell repair
  • BPC-157 demonstrated potential in tendon/muscle repair but findings largely unvalidated in human trials
  • TB-4/TB-500 promoted angiogenesis in preclinical models but human orthopaedic data lacking
  • GHK-Cu shows promise for wound healing
  • Critical gap between preclinical evidence and clinical validation across all peptides

Summary

Comprehensive narrative review evaluating the most popular injectable therapeutic peptides for orthopaedic injuries. Conducted via PubMed literature search focusing on biochemical and clinical studies. Evaluates BPC-157, TB-4/TB-500, CJC-1295 + ipamorelin, tesamorelin, and GHK-Cu for musculoskeletal applications.

Key Findings

  • CJC-1295 + ipamorelin combination activates IGF-1 signaling cascade, promoting satellite cell repair in muscle tissue
  • The GHRH + GHRP synergy produces amplified GH pulses beneficial for recovery
  • However, no dedicated clinical trials for orthopaedic applications exist
  • BPC-157 has a single human case series (with methodological flaws)
  • The review emphasizes the critical need for controlled clinical trials

Relevance to CJC-1295

Positions the CJC-1295 + Ipamorelin stack within orthopaedic medicine. The IGF-1 signaling and satellite cell repair mechanism is the primary pathway by which GH secretagogues would benefit musculoskeletal recovery. Highlights the evidence gap while acknowledging mechanistic plausibility.

Citation

Orthopaedic Review. 2026. PMID: 41490200

See Also

View on PubMed · PMID 41490200 →